Repair Impact Fund

About

Novo Holdings established the REPAIR Impact Fund commissioned by the Novo Nordisk Foundation in February 2018 to invest in companies involved in discovering and the early-stage development of therapies targeting resistant microorganisms. REPAIR is an acronym: Replenishing and Enabling the Pipeline for Anti-Infective Resistance. The Novo Nordisk Foundation is commissioning the initiative, and Novo Holdings is executing it.

Investment Focus

Stages

growth

Location

Hellerup, Denmark